Metalytic's CoreMFA enables analyses and visualizations of the metabolic pathways in cells that biotechnology and pharmaceutical companies can use to improve their production process or solve production issues.
WHAT WE DO
Metalytics provides tools to measure and understand the relationships among nutrient utilization, metabolic efficiency, cell growth and how the cell assembles building blocks to construct the final product. We do this via our customized and proprietary metabolic flux analysis process.
We Optimize and Accelerate Your Bioprocessing Research, Development, and Manufacturing
Modeling metabolic reaction rates in cell factories
Deploying metabolic flux analysis with advanced, proprietary software systems
Accelerating R&D and process improvements
Improving efficiency and productivity
Solving complex production issues
We Give You a Competitive Advantage
Increased production capacity & efficiency
Engineered cell lines
Optimized culture media
Reduced raw material costs
Accelerated time to market
Increased ROI and profitability
HOW CAN WE HELP YOU?
By providing critical information about cellular metabolic rates in living cells, CoreMFA allows investigators to quickly and rationally engineer improved cells for biomanufacturing. By highlighting the most promising targets in metabolism, reduced time-to-market, increased productive output and production capacity, lower capital requirements, and reduced raw material costs can be achieved.
We explore your challenges, identify desired outcomes, and develop a plan of action.
We provide detailed protocols customized to your cell line and culture conditions.
You simply send us your samples. We'll generate flux data and maps, provide data analysis and
interpretation, and produce actionable results that will inform and prioritize your next steps.
“We use yeast and E.coli to manufacture commodities and specialty chemicals. We wanted to know the metabolic flux and tried 7 different approaches, but Metalytics’ technology was the best thing for understanding what was going on.” - Dr. Joshua Lerman, Amyris